INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $737,000 | +27.5% | 43,625 | 0.0% | 0.50% | +31.7% |
Q3 2014 | $578,000 | +1.0% | 43,625 | -2.9% | 0.38% | +10.4% |
Q2 2014 | $572,000 | +31.8% | 44,925 | -3.0% | 0.35% | +14.2% |
Q1 2014 | $434,000 | -21.4% | 46,325 | +2.0% | 0.30% | -18.5% |
Q4 2013 | $552,000 | -56.8% | 45,425 | -39.1% | 0.37% | -66.3% |
Q3 2013 | $1,278,000 | – | 74,575 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
Bleichroeder LP | 250,000 | $298,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |